Characterization of an apparently nononcogenic Marek's disease virus.
A new isolate of Marek's disease virus (MDV) was described. This virus, SB, and a clone, SB-1, differed from pathogenic isolates in in vitro growth characteristics as described for other apathogenic isolates. Serologically, as with other apathogenic isolates, SB could be distinguished from pathogenic MDV and the avirulent turkey herpesvirus. SB failed to induce lesions characteristic of Marek's disease (MD) during a 6- to 11-week experimental period. Also, SB was nononcogenic in immunosuppressed chickens or in chickens inoculated with this virus in ovo. However, under those conditions, SB caused a cytolytic infection. The term "nononcogenic" rather than "apopathogenic" was therefore proposed to classify this and similar isolates. SB-1 protected chickens against challenge with either virulent MDV or the non-virus-producing MD tumor transplant, JMV. Possible mechanisms of protection are discussed.
D000818:Animals; D000956:Antigens, Viral; D002645:Chickens; D002999:Clone Cells / Q000382:microbiology; D003588:Cytopathogenic Effect, Viral; D000939:Epitopes; D008381:Herpesvirus 2, Gallid / Q000276:immunology / Q000302:isolation & purification / Q000472:pathogenicity*; D007109:Immunity; D007165:Immunosuppression Therapy; D008380:Marek Disease / Q000209:etiology / Q000517:prevention & control; D009374:Neoplasms, Experimental / Q000276:immunology
D000956:Antigens, Viral; D000939:Epitopes